本资料来自随机双盲对照法评价阿司匹林-潘生丁联合用药防止 PTCA后 7个月内发生再狭窄调查试验。行 PTCA前将所有同意参加本试验的病人随机分入阿司匹林-潘生丁联合用药组及安慰剂对照组、在行PTCA后的4—7个月内(除非症状复发需在4个月内行冠脉造影)力争再做一次冠脉造影。共有1,895例病人登记行PTCA,剔除后376例病人随机分入药物组及安慰剂组。最 This data from the randomized double-blind control method to evaluate aspirin - dipyridamole combination therapy to prevent restenosis within 7 months after PTCA investigation. Before PTCA, all patients who agreed to participate in the trial were randomly assigned to aspirin-dipyridamole combination therapy and placebo control group, within 4-7 months after PTCA (unless the recurrence of symptoms within 4 months of coronary angiography Strive to make a coronary angiography. A total of 1,895 patients were enrolled in PTCA, and 376 patients were randomly assigned to receive either placebo or placebo. most